Updated Date:
02 Mar 2026
Product Detail:
EPILIM sodium valproate 100mg crushable tablet blister pack
Shortage Status:
Discontinued
AUST R:
15373
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
sodium valproate
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Tablet,uncoated
Supply Impact Dates
Management Action:
There is a current shortage with limited availability until 15 April 2026. An overseas-registered product has been approved for supply under section 19A. The approval holder, Sanofi Aventis, can be contacted for details on supply on 1800 818 806. Supply is expected to return to normal after 15 April 2026 and continue until the medicine is deleted from the market on 30 September 2026